(E)-3-(2-((5-bromoquinoxalin-6-yl)amino)-4,5-dihydro-1H-imidazol-1-yl)acrylicacid
5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline for method validation 5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline reference standard 5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline for ANDA filing 5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline for forced degradation studies 5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline identification standard 5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline for DMF filing 5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline HPLC standard 5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline supplier 5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline manufacturer 5-bromo-6-(imidazolin-4-on-2-yl)aminoquinoxaline distributor
